Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSTCK.L Regulatory News (STCK)

  • There is currently no data for STCK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)- Stock Spirits Group plc Amend

12 Nov 2021 16:05

RNS Number : 2859S
JPMorgan Securities Plc
12 November 2021
 

AMENDMENT

 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

J.P. Morgan Securities Plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Stock Spirits Group plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Financial Adviser and Corporate Broker to Stock Spirits Group PLC.

(d) Date dealing undertaken:

10 November 2021

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

10p ordinary

Purchase

 

Sale

212,215

 

194,255

3.7453 GBP

 

3.7450 GBP

3.7400 GBP

 

3.7400 GBP

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

10p ordinary

Equity Swap

Decrease Short

 

Increase Short

 

 

 

Opening a long position

 

 

Opening a short position

24,936

 

50,000

7,022

4,000

 

1,567

30,570

 

32,137

3.7397 GBP

 

3.7411 GBP

3.7445 GBP

3.7453 GBP

 

3.7448 GBP

3.7450 GBP

 

3.7450 GBP

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

Date of disclosure:

12 November 2021

Contact name:

Alwyn Basch

Telephone number:

020 7742 7407

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERFLFIRLSLFLIL
Date   Source Headline
18th Dec 20202:00 pmRNSAnnual Financial Report
11th Dec 20203:26 pmRNSDirector/PDMR Shareholding
7th Dec 20202:13 pmRNSHolding(s) in Company
2nd Dec 20207:00 amRNSPreliminary Results
26th Nov 20208:01 amRNSHolding(s) in Company
9th Nov 202011:43 amRNSHolding(s) in Company
23rd Oct 20203:28 pmRNSDirector/PDMR Shareholding
14th Oct 20207:00 amRNSTrading Statement and Notice of Results
29th Jun 20207:18 amRNSDirector Declaration
29th May 20203:55 pmRNSHolding(s) in Company
15th May 20203:02 pmRNSDirector/PDMR Shareholding
13th May 20207:00 amRNSHalf-year Report
25th Mar 20207:00 amRNSStock Spirits begins hand sanitiser production
19th Mar 20207:41 amRNSDirector/PDMR Shareholding
13th Feb 20202:58 pmRNSShare Scheme Awards
6th Feb 202011:29 amRNSAGM Poll Results
6th Feb 20207:00 amRNSAGM Trading Statement
24th Jan 20204:39 pmRNSHolding(s) in Company
20th Dec 20196:00 pmRNSAnnual Financial Report
19th Dec 20197:49 amRNSHolding(s) in Company
4th Dec 20197:00 amRNSPreliminary Results
22nd Oct 20194:53 pmRNSHolding(s) in Company
22nd Oct 20194:52 pmRNSHolding(s) in Company
8th Oct 20197:00 amRNSPre-Close Trading Update and Notice of Results
23rd Jul 20191:16 pmRNSHolding(s) in Company
25th Jun 20197:00 amRNSCapital Markets Day in the Czech Republic
10th Jun 201910:20 amRNSDirector Declaration
14th May 20197:00 amRNSInterim Results 2019
22nd Feb 20192:01 pmRNSDirector/PDMR Shareholding
14th Feb 20193:30 pmRNSResult of AGM
14th Feb 20197:00 amRNSAGM Trading Statement
31st Jan 20197:00 amRNSAcquisition of Distillerie Franciacorta SpA
9th Jan 201911:46 amRNSAnnual Financial Report and Notice of AGM
5th Dec 20187:00 amRNSPreliminary Results
6th Nov 20186:30 pmRNSHolding(s) in Company
9th Oct 20187:00 amRNSPre-Close Trading Update
21st Sep 201812:05 pmRNSBoard Change
11th Sep 201812:44 pmRNSHolding(s) in Company
7th Sep 201812:52 pmRNSHolding(s) in Company
10th Aug 20189:03 amRNSDirector/PDMR Shareholding
9th Aug 20187:00 amRNSAnalyst Teach-In
8th Aug 20187:00 amRNSResults for the six months ended 30 June 2018
22nd May 201812:51 pmRNSResult of AGM
22nd May 20187:00 amRNSAGM Trading Statement
5th Apr 20183:57 pmRNSAnnual Financial Report and Notice of AGM
23rd Mar 201810:01 amRNSDirector/PDMR Shareholding
19th Mar 20184:29 pmRNSAmendment to Director/PDMR Shareholding
15th Mar 20184:03 pmRNSDirector/PDMR Shareholding
7th Mar 20187:00 amRNSFinal Results
9th Jan 20189:18 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.